RAN and neoplasm: Although RCC1 is also expressed in normal cells and can prevent the aging and death of normal cells due to DNA damage, the use of RAN-IP may have an impact on normal cells, but tumor cells are more affected after reducing Ran levels (Yuen et al., 2013; Yuen et al., 2016).